• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Sodium-glucose co-transporter 2 inhibitors: strength of evidence for a cardio-renal-metabolic therapy.

作者信息

Parcha Vibhu, Arora Pankaj

机构信息

Division of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham, AL, USA.

Section of Cardiology, Birmingham Veterans Affairs Medical Center, Birmingham, AL, USA.

出版信息

Eur J Heart Fail. 2021 Jun;23(6):1009-1011. doi: 10.1002/ejhf.2172. Epub 2021 Apr 5.

DOI:10.1002/ejhf.2172
PMID:33779117
Abstract
摘要

相似文献

1
Sodium-glucose co-transporter 2 inhibitors: strength of evidence for a cardio-renal-metabolic therapy.
Eur J Heart Fail. 2021 Jun;23(6):1009-1011. doi: 10.1002/ejhf.2172. Epub 2021 Apr 5.
2
Sodium-glucose co-transporter 2 inhibitors: 'a tale of two sisters', diabetes and heart failure.
Eur J Heart Fail. 2020 Jul;22(7):1259-1262. doi: 10.1002/ejhf.1935. Epub 2020 Jul 14.
3
Heart Failure Association of the European Society of Cardiology update on sodium-glucose co-transporter 2 inhibitors in heart failure.欧洲心脏病学会心力衰竭协会关于心力衰竭钠-葡萄糖协同转运蛋白 2 抑制剂的更新。
Eur J Heart Fail. 2020 Nov;22(11):1984-1986. doi: 10.1002/ejhf.2026. Epub 2020 Oct 27.
4
Treatment of heart failure with sodium glucose co-transporter-2 inhibitors in people with type 2 diabetes mellitus: current evidence and future directions.钠-葡萄糖共转运蛋白 2 抑制剂治疗 2 型糖尿病心力衰竭患者：当前证据与未来方向。
Diabet Med. 2019 Dec;36(12):1550-1561. doi: 10.1111/dme.14140. Epub 2019 Oct 10.
5
Chronic obstructive pulmonary disease and comorbidities in heart failure: the next frontier of sodium-glucose co-transporter 2 inhibitors?慢性阻塞性肺疾病与心力衰竭合并症：钠-葡萄糖协同转运蛋白2抑制剂的下一个前沿领域？
Eur J Heart Fail. 2021 Apr;23(4):644-647. doi: 10.1002/ejhf.2109. Epub 2021 Feb 5.
6
EMPEROR-Reduced: confirming sodium-glucose co-transporter 2 inhibitors as an essential treatment for patients with heart failure with reduced ejection fraction.EMPEROR-Reduced研究：证实钠-葡萄糖协同转运蛋白2抑制剂是射血分数降低的心力衰竭患者的重要治疗方法。
Eur J Heart Fail. 2020 Nov;22(11):1987-1990. doi: 10.1002/ejhf.2006. Epub 2020 Oct 2.
7
Epicardial adipose tissue: does it mediate the cardio-protective effects of sodium-glucose co-transporter 2 inhibitors in patients with heart failure? Letter regarding the article 'Impact of epicardial adipose tissue on cardiovascular haemodynamics, metabolic profile, and prognosis in heart failure'.心外膜脂肪组织：它是否介导了钠-葡萄糖协同转运蛋白2抑制剂对心力衰竭患者的心脏保护作用？关于文章《心外膜脂肪组织对心力衰竭患者心血管血流动力学、代谢谱和预后的影响》的信函
Eur J Heart Fail. 2022 Feb;24(2):400-401. doi: 10.1002/ejhf.2412. Epub 2022 Jan 5.
8
Reply to 'Epicardial adipose tissue: does it mediate the cardio-protective effects of sodium-glucose co-transporter 2 inhibitors in subjects with heart failure?' Letter regarding the article 'Impact of epicardial adipose tissue on cardiovascular haemodynamics, metabolic profile, and prognosis in heart failure'.对《心外膜脂肪组织：它是否介导了钠-葡萄糖协同转运蛋白2抑制剂对心力衰竭患者的心脏保护作用？》的回复 关于文章《心外膜脂肪组织对心力衰竭患者心血管血流动力学、代谢谱及预后的影响》的信函
Eur J Heart Fail. 2022 Feb;24(2):401. doi: 10.1002/ejhf.2423. Epub 2022 Jan 18.
9
Focused Updates: SGLT2 Inhibitors in Patients With Heart Failure and/or Chronic Kidney Disease.重点更新：心力衰竭和/或慢性肾脏病患者的 SGLT2 抑制剂。
Ann Pharmacother. 2021 Feb;55(2):252-260. doi: 10.1177/1060028020934001. Epub 2020 Jun 13.
10
Sodium-glucose co-transporter 2 inhibitors and acute heart failure.钠-葡萄糖协同转运蛋白2抑制剂与急性心力衰竭
Eur J Heart Fail. 2020 Apr;22(4):723-725. doi: 10.1002/ejhf.1759. Epub 2020 Feb 18.